Catalent’s cell therapy expertise and network spans globally with facilities across the US and Europe. To meet the high standards for our customers, we have built and developed world-class development and manufacturing centers across the globe that are equipped with industry-leading talent, technologies, and high-quality processes. Additionally, we are well-suited to offer capabilities for viral vector production at our state-of-art gene therapy facilities located across the state of Maryland, USA.

Catalent’s cell therapy clinical facilities are located in Europe (Gosselies, Belgium) and the USA (Houston, Texas).

Gosselies, Belgium Clinical Manufacturing Facility

• FDA/EMA compliant facility and quality systems
• ~26,000 sq. ft. of clinical manufacturing space
  • 9 CGMP clean rooms with independent HVAC/Agile shutdown
  • 4 process development labs
  • Flexible manufacturing space
  • In-house Quality Control
  • Scale-up and scale-out of autologous and allogeneic programs
  • Grade B storage
  • Nitrogen storage
  • Fill/finish services

Gosselies, Belgium Commercial Campus

• 60,000 sq. ft. of commercial space
• Dedicated commercial suites
• Next-generation fill/finish platform
• QC testing labs

Our newest large-volume commercial production capacity will be located both in Gosselies, Belgium, and is expected to be commissioned in 2021 with state-of-the-art design to meet current quality standards.

Houston, Texas Clinical Manufacturing Facility

• FDA/EMA compliant facility
• ~32,000 sq. ft. of manufacturing space
  • 8 cGMP clean rooms with independent HVAC/Agile shutdown
  • 3 development labs
  • In-house Quality Control
  • Flexible manufacturing space
  • Scale-up and scale-out of autologous and allogeneic programs
  • Grade B storage
  • Nitrogen storage
  • Fill/finish services